ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,430Medicare Part D Prescriptions Filled, Including Refills

Rank: 364 out of 2680

$407K Total Retail Price of All Prescriptions

Rank: 556 out of 2680

158 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 158 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,028 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 448 439 1 2
LEVOTHYROXINE SODIUM 318 298 2 4
FUROSEMIDE 273 264 3 7
SIMVASTATIN 229 219 4 1
WARFARIN SODIUM 227 186 5 12
LANTUS 211 200 6 70
POTASSIUM CHLORIDE 197 185 7 29
DONEPEZIL HCL 186 186 8 28
METOPROLOL TARTRATE 161 143 9 8
CITALOPRAM HBR 155 144 10 22
TRAMADOL HCL 144 144 11 33
RISPERIDONE 141 141 12 67
GABAPENTIN 140 140 13 21
NAMENDA 133 133 14 43
LISINOPRIL 128 128 15 5
METOPROLOL SUCCINATE 122 114 16 11
ATENOLOL 120 115 17 14
DIVALPROEX SODIUM 119 119 18 90
NOVOLIN R 111 111 19 210
HYDROCHLOROTHIAZIDE 94 85 20 9
ALBUTEROL SULFATE 91 77 21 97
SERTRALINE HCL 85 85 22 23
VENLAFAXINE HCL ER 79 79 23 111
AMLODIPINE BESYLATE 74 74 24 3
OLANZAPINE 72 72 25 128
LACTULOSE 72 72 25 100
PAROXETINE HCL 68 68 27 62
TAMSULOSIN HCL 67 67 28 25
ISOSORBIDE MONONITRATE ER 62 54 29 57
CEPHALEXIN 61 59 30 132
CARBIDOPA-LEVODOPA 59 50 31 88
TRAZODONE HCL 57 53 32 60
ROPINIROLE HCL 55 55 33 143
PANTOPRAZOLE SODIUM 53 43 34 44
SYMBICORT 52 52 35 114
OXYCONTIN 52 52 S2 35 178
SUCRALFATE 50 50 37 269
CYMBALTA 50 50 37 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.